Table 2.
Indications for hysteroscopy.
| Total 1 | Bucharest | Timișoara | |
|---|---|---|---|
| (N = 368) (100%) | (N = 45) (100%) | (N = 323) (100%) | |
| IUD retention 2 | 19 (5.16%) | 0 (0.00%) | 19 (5.88%) |
| AUB 3 | 131 (35.59%) | 36 (80.00%) | 95 (29.41%) |
| Postmenopausal | 15 (4.07%) | 1 (2.22%) | 14 (4.33%) |
| Endometrial thickening | 41 (11.14%) | 7 (15.55%) | 34 (10.52%) |
| Hypertrophy | 17 (4.61%) | 0 (0.00%) | 17 (5.26%) |
| Hyperplasia | 24 (6.52%) | 7 (15.55%) | 17 (5.26%) |
| Uterine myoma | 55 (14.94%) | 18 (40.00%) | 37 (11.45%) |
| Intracavitary | 19 (5.16%) | 1 (2.22%) | 18 (5.57%) |
| Chronic pelvic pain | 11 (2.98%) | 3 (6.66%) | 8 (2.47%) |
| Adenomyosis | 6 (1.63%) | 2 (4.44%) | 4 (1.23%) |
| Infertility | 68 (18.47%) | 7 (15.55%) | 61 (18.88%) |
| primary | 36 (9.78%) | 2 (4.44%) | 34 (10.52%) |
| secondary | 25 (6.79%) | 5 (11.11%) | 20 (6.19%) |
| Uterine septum | 3 (0.81%) | 0 (0.00%) | 3 (0.92%) |
| Polyps | 153 (41.57%) | 25 (55.55%) | 128 (39.62%) |
| Cervical polyp | 12 (3.26%) | 4 (8.88%) | 8 (2.47%) |
| Endometrial polyp | 140 (38.04%) | 21 (46.66%) | 119 (36.84%) |
| Isthmocele | 2 (0.54%) | 0 (0.00%) | 2 (0.61%) |
1 Data are presented as N (%); 2 IUD: intrauterine device; 3 AUB: abnormal uterine bleeding.